Elisabeth Becker



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study (2021) Mühl L, Becker E, Müller T, Atreya R, Atreya I, Neurath M, Zundler S Journal article Targeting Immune Cell Trafficking – Insights From Research Models and Implications for Future IBD Therapy (2021) Wiendl M, Becker E, Müller T, Voskens C, Neurath M, Zundler S Journal article, Review article Circulating Adaptive Immune Cells Expressing the Gut Homing Marker α4β7 Integrin Are Decreased in COVID-19 (2021) Müller T, Becker E, Wiendl M, Schulze L, Voskens C, Kremer A, Neurath M, et al. Journal article Baseline levels of dynamic CD4+ T cell adhesion to MAdCAM-1 correlate with clinical response to vedolizumab treatment in ulcerative colitis: a cohort study (2020) Allner C, Melde M, Becker E, Fuchs F, Mühl L, Klenske E, Müller L, et al. Journal article Dose-dependent differential effects of vedolizumab therapy on adhesion of regulatory and effector T cells (2020) Becker E, Wiendl M, Schulz-Kuhnt A, Atreya I, Atreya R, Neurath M, Zundler S Conference contribution Immune cell trafficking and retention in inflammatory bowel disease: Mechanistic insights and therapeutic advances (2019) Zundler S, Becker E, Schulze L, Neurath M Journal article Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healing (2019) Schleier L, Wiendl M, Heidbreder K, Binder MT, Atreya R, Rath T, Becker E, et al. Journal article Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease (2018) Becker E, Schramm S, Binder MT, Allner C, Wiendl M, Neufert C, Atreya I, et al. Journal article